Document is current
Any future updates will be listed below
-
Authors
Linnstaedt, Sarah D. https://orcid.org/0000-0001-5295-7072
Zannas, Anthony S.
McLean, Samuel A. https://orcid.org/0000-0001-9482-3582
Koenen, Karestan C.
Ressler, Kerry J.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01MH110925)
- License Information
-
More Information
Article History
Received: 7 July 2019
Revised: 24 November 2019
Accepted: 11 December 2019
First Online: 20 December 2019
Compliance with ethical standards
:
: KJR provides fee-for-service consultation for Johnson & Johnson, Verily, and Alkermes. He has received sponsored research unrelated to this work from Brainsway and Takeda. He also holds patents for a number of targets related to improving extinction of fear, however, he has received no equity or income within the last 3 years related to these. He receives or has received research funding from NIMH, NIAAA, HHMI, NARSAD, and the Burroughs Wellcome Foundation. The other authors declare no conflicts of interest.
